The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Julia Kirchheiner

Institute of Pharmacology of Natural Products and Clinical Pharmacology

University of Ulm

Germany

[email]@uni-ulm.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Germany. 2006 - 2011
  • Institute of Clinical Pharmacology, Charité University Medicine, Berlin, Germany. 2008

References

  1. CYP2D6 in the brain: genotype effects on resting brain perfusion. Kirchheiner, J., Seeringer, A., Godoy, A.L., Ohmle, B., Maier, C., Beschoner, P., Sim, E.J., Viviani, R. Mol. Psychiatry (2011) [Pubmed]
  2. Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?. Kirchheiner, J., Seeringer, A., Viviani, R. Curr. Pharm. Des. (2010) [Pubmed]
  3. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., Brockmöller, J. Eur. J. Clin. Pharmacol. (2009) [Pubmed]
  4. Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders. Kirchheiner, J., Rodriguez-Antona, C. CNS. Drugs (2009) [Pubmed]
  5. Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids. Kirchheiner, J., Meineke, I., Fuhr, U., Rodríguez-Antona, C., Lebedeva, E., Brockmöller, J. Pharmacogenomics (2008) [Pubmed]
  6. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. Kirchheiner, J., Keulen, J.T., Bauer, S., Roots, I., Brockmöller, J. J. Clin. Psychopharmacol (2008) [Pubmed]
  7. Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Kirchheiner, J., Lorch, R., Lebedeva, E., Seeringer, A., Roots, I., Sasse, J., Brockmöller, J. Pharmacogenomics (2008) [Pubmed]
  8. CYP2D6 phenotype prediction from genotype: which system is the best? Kirchheiner, J. Clin. Pharmacol. Ther. (2008) [Pubmed]
  9. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Kirchheiner, J., Schmidt, H., Tzvetkov, M., Keulen, J.T., Lötsch, J., Roots, I., Brockmöller, J. Pharmacogenomics J. (2007) [Pubmed]
  10. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Kirchheiner, J., Nickchen, K., Sasse, J., Bauer, M., Roots, I., Brockmöller, J. Pharmacogenomics J. (2007) [Pubmed]
  11. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. Kirchheiner, J., Seeringer, A. Biochim. Biophys. Acta (2007) [Pubmed]
  12. Contribution of allelic variations in transporters to the phenotype of drug response. Kirchheiner, J., Gründemann, D., Schömig, E. J. Psychopharmacol. (Oxford) (2006) [Pubmed]
  13. Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype. Kirchheiner, J., Thomas, S., Bauer, S., Tomalik-Scharte, D., Hering, U., Doroshyenko, O., Jetter, A., Stehle, S., Tsahuridu, M., Meineke, I., Brockmöller, J., Fuhr, U. Clin. Pharmacol. Ther. (2006) [Pubmed]
 
WikiGenes - Universities